OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed
This is a forecasted opportunity — a pre-announcement that isn’t open for applications yet. Dates and details may change before it posts.
This is a forecasted FDA Office of Minority Health and Health Equity cooperative agreement (U01) to expand education on the risks of skin-lightening products; clinical trials are not allowed. It is…
- Deadline
- Not specified
- Posted
- Dec 12, 2023
- Award amount
- Amount not specified
In plain English
This is a forecasted FDA Office of Minority Health and Health Equity cooperative agreement (U01) to expand education on the risks of skin-lightening products; clinical trials are not allowed. It is not yet open, and eligibility, budget, and deadline have not been posted. FDA U01 education awards typically go to nonprofits, universities, and public-health organizations, so check the full notice for specific eligibility before applying.
AI-generated summary to help you decide quickly — verify the official eligibility rules before applying.
Let AI draft your application
Your first draft is free: a narrative and budget outline tailored to this grant, emailed to you. Drafts are written in a nightly batch, so it arrives by email later — not instantly on this page.
Application Kit — $49 one-time
Winner intelligence + a first-draft narrative grounded in applications that actually won. One payment, no subscription.
Get the Application Kit →Related grants
Other open grants from Food and Drug Administration — soonest deadline first.
Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed
Food and Drug Administration · Amount varies · No deadline listed
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Food and Drug Administration · Up to $600K · Due Feb 8, 2028
Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Food and Drug Administration · Up to $900K · Due May 16, 2028
Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
Food and Drug Administration · Amount varies · No deadline listed
Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional
Food and Drug Administration · Amount varies · No deadline listed
Studies Addressing Rare Neurodegenerative Diseases including ALS
Food and Drug Administration · Amount varies · No deadline listed
Also listed under Food and Drug Administration.
Source: public records via Grants.gov. UseGrants is an independent aggregator, not affiliated with any funding agency. Always confirm details on the official listing before applying.